DrugInformer Search


Average User Review Score
* Based on 0 reviews from across the web.

No description available.


  Please use Workbench for in-depth research on Amitriptyline.

* Extracted from FDA Adverse Event Reports for all drugs with the same active ingredients.

Tell us about your Experience with Amitriptyline

Thank you for sharing your experience with us!

Share Your Experience

Druginformer Identified Side Effects: Somnolence, Abnormal dreams, Dry mouth

Effectiveness Rating:     Overall Rating:

Posted By Samantha on March 15, 2019 @ 9:07 pm

I’ve been on ami for over a year now to help with postshingles and endometriosis related pain. The tiredness, the lethargy, and grogginess took months to pass. I persisted with it and found taking it at night about 7pm was good as the main bulk of grogginess had passed by about 10am but for the first two months I was fast asleep within an hour of taking the drug (20mg at night). I have never been a dreamer, or at least I have never remembered anything I have dreamed. I just black out at night, but I started getting very vivid insane dreams, sometimes nightmares that I would wake up in a sweat shaking from. Most were just bizarre rather than frightening.

* Warning: The facts and figures contained in these reports are accurate to the best of our capability; however, our metrics are only meant to augment your medical knowledge, and should never be used as the sole basis for selecting a new medication. As with any medical decision, be sure to work with your doctor to ensure the best choices are made for your condition.

* About FAERS: The FDA Adverse Event Reporting System (FAERS) is used by FDA for activities such as looking for new safety concerns that might be related to a marketed product, evaluating a manufacturer's compliance to reporting regulations and responding to outside requests for information. Reporting of adverse events is a voluntary process, and not every report is sent to FDA and entered into FAERS. The FAERS database may contain duplicate reports, the report quality is variable, and many factors may influence reporting (e.g., media attention, length of time a drug is marketed, market share). For these reasons, FAERS case reports cannot be used to calculate incidence or estimates of risk for a particular product or compare risks between products.